Predictive and prognostic value of FDG-PET

nork de Geus-Oei, Lioe-Fee, Oyen, Wim J.G.
Argitaratua 2008

Nuclear medicine imaging and therapy of neuroendocrine tumours

nork Gotthardt, Martin, Dijkgraaf, Ingrid, Boerman, Otto C, Oyen, Wim J G
Argitaratua 2006

Radiolabelled peptides for oncological diagnosis

nork Laverman, Peter, Sosabowski, Jane K., Boerman, Otto C., Oyen, Wim J. G.
Argitaratua 2012

Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies

nork Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Argitaratua 2006

Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care

nork Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Argitaratua 2006

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET

nork Brom, Maarten, Oyen, Wim J. G., Joosten, Lieke, Gotthardt, Martin, Boerman, Otto C.
Argitaratua 2010

Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas

nork Brom, Maarten, Joosten, Lieke, Oyen, Wim J.G., Gotthardt, Martin, Boerman, Otto C.
Argitaratua izan da Contrast Media Mol Imaging (2012)

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment

nork Quak, Elske, Kovacs, Iringo, Oyen, Wim J. G., van der Graaf, Winette T. A.
Argitaratua izan da Nucl Med Mol Imaging (2015)

Methodological considerations in quantification of oncological FDG PET studies

nork Vriens, Dennis, Visser, Eric P., de Geus-Oei, Lioe-Fee, Oyen, Wim J. G.
Argitaratua 2009

Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations

nork van Dalen, Jorn A., Vogel, Wouter V., Corstens, Frans H.M., Oyen, Wim J.G.
Argitaratua 2007

Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study

nork Schinagl, Dominic A. X., Span, Paul N., Oyen, Wim J., Kaanders, Johannes H. A. M.
Argitaratua 2011

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma

nork Gilles, Rozemarie, de Geus-Oei, Lioe-Fee, Mulders, Peter F. A., Oyen, Wim J. G.
Argitaratua 2011

Radiolabeled antibodies in renal cell carcinoma

nork Stillebroer, Alexander B., Oosterwijk, Egbert, Oyen, Wim J.G., Mulders, Peter F.A., Boerman, Otto C.
Argitaratua 2007

Antibody therapy in renal cell carcinoma

nork Oosterwijk, Egbert, Boerman, Otto C., Oyen, Wim J. C., Old, Lloyd J., Mulders, Peter F. A.
Argitaratua 2008

Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides

nork Vegt, Erik, Eek, Annemarie, Oyen, Wim J. G., de Jong, Marion, Gotthardt, Martin, Boerman, Otto C.
Argitaratua 2009

Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy

nork Bashir, Usman, Tree, Alison, Mayer, Erik, Levine, Daniel, Parker, Chris, Dearnaley, David, Oyen, Wim J. G.
Argitaratua izan da Eur J Nucl Med Mol Imaging (2019)

Colorectal cancer: the role of PET/CT in recurrence: Wednesday 5 October 2005, 14:00–16:00

nork Vogel, Wouter V, Wiering, Bastiaan, Corstens, Frans H M, Ruers, Theo J M, Oyen, Wim J G
Argitaratua 2005

F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection

nork Simons, Koen S., Pickkers, Peter, Bleeker-Rovers, Chantal P., Oyen, Wim J. G., van der Hoeven, Johannes G.
Argitaratua 2009

Preclinical Evaluation of (68)Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor–Positive Tumors

nork Brom, Maarten, Joosten, Lieke, Laverman, Peter, Oyen, Wim J.G., Béhé, Martin, Gotthardt, Martin, Boerman, Otto C.
Argitaratua 2011

Nuclear Medicine Imaging of Infection in Cancer Patients (With Emphasis on FDG-PET)

nork Bleeker-Rovers, Chantal P., Vos, Fidel J., van der Graaf, Winette T.A., Oyen, Wim J.G.
Argitaratua 2011